In Ando et al., 2017 , numerical errors in the axonal rate were published in Results and Discussion sections and 
Results (page 193)
We analyzed 1,334 unrelated patients with clinically suspected CMT. We detected 30 known pathogenic mutations, 1 novel pathogenic mutation, 14 novel likely pathogenic variants of MFN2, from which 44 were heterozygous mutations and 1 was compound heterozygous mutation. Of the CMT patients without PMP22 duplication/deletion, 801 patients (60%) presented the axonal phenotype, and 367 patients (28%) were classified as having the demyelinating type. We could not classify 166 patients due to a non-recordable median compound motor action potential (CMAP) or no electrophysiological data. These CMT patients with axonal phenotype showed an MFN2 mutation rate of 8%, 62/801 (Fig. 1A) .
Discussion (page 197)
In this Japanese case series, we detected MFN2 mutations in 79 of 1,334 CMT patients without a PMP22 deletion/duplication. The MFN2 mutation accounted for 16% of the CMT2 patients in a Spanish cohort study, and 18% of CMT2 without MPZ and GJB1 mutations in French patients (Calvo et al., 2009; Casasnovas et al., 2010) . In Asia, MFN2 was the cause of CMT2 in 23% of Korean CMT2 patients and 18% of Chinese CMT2 patients (Choi et al., 2015; Xie et al., 2016) . The frequency of MFN2 mutations is low, between 9% and 11%, as previously reported in a Japanese population study (Kijima et al., 2005; Abe et al., 2011) . Here, we show a frequency of the MFN2 mutation of 8% (62/801) in Japanese CMT2 patients. A frequency of 28%-34% for sporadic or de novo mutations has been previously reported (Verhoeven et al., 2006; Choi et al., 2015) . However, sporadic cases reached a frequency of 46% in our study. This incidence rate is higher than that reported from other countries. The low frequency of MFN2 mutations and high frequency of sporadic cases might indicate the influence of geographical and social distribution, although there is a possibility of an incomplete family history.
Figure. 1 (page 193)
A The pie chart of diagnostic rate in axonal CMT should have been 7.7 instead of 7.9 in MFN2 rate and 20.5 instead of 8.7 in Other genes.
We apologize for these errors.
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